MPS Pharmaa Limited (BOM:531686)

India · Delayed Price · Currency is INR

1.810

0.00 (0.00%)

At close: Jun 15, 2026

-34.42% (1Y)

Market Cap	34.59M +402.8%
Revenue (ttm)	356.00K -25.4%
Net Income	-10.20M
EPS	-0.53
Shares Out	19.11M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25
Open	1.810
Previous Close	n/a
Day's Range	1.810 - 1.810
52-Week Range	1.570 - 3.010
Beta	-0.03
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About MPS Pharmaa

MPS Pharmaa Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers generic products, including antibacterials, antiallergics, antifungals, anthelminthics, antihypertensives, antimalarials, antituberculosis, corticosteroids, erectile dysfunction, gastrointestinal agents, sedatives, and others, as well as analgesic, antipyretic, and anti-inflammatory products. It also offers ethical products, such as Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin, and Chewfe-... [Read more]

Industry Pharmaceutical Preparations

Founded 1994

Employees 18

Stock Exchange Bombay Stock Exchange

Ticker Symbol 531686

Full Company Profile

Financial Performance

In fiscal year 2026, MPS Pharmaa's revenue was 356,000, a decrease of -25.40% compared to the previous year's 477,204. Losses were -10.20 million, 13.6% more than in 2025.

Financial Statements